RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TORRI V
Collezione AOU Alessandria

Items : 9

Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund. in Tumori / Tumori. 2024 Jun;110(3):168-173. doi: 10.1177/03008916241229287. Epub 2024 Feb 19.

2024
ASL Cuneo 2
AOU Alessandria
ASL Città di Torino

Grosso F; Garassino MC; Ceresoli GL; Pasello G; Petraglia S; De Simone I; Cuppone F; Gauna R; Verderame F; Alabiso I; Dellepiane C; Biello F; Lo Russo G; Occhipinti M; Proto C; Mazzeo L; De Angelis AM; Torri V; Crivellari S; Delfanti S; Cerbone L;

A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2022 May;17(5):661-674. doi: 10.1016/j.jtho.2021.12.015. Epub 2022 Feb 1.

2022
AOU Alessandria

Whisenant JG; Baena J; Cortellini A; Huang LC; Lo Russo G; Porcu L; Wong SK; Bestvina CM; Hellmann MD; Roca E; Rizvi H; Monnet I; Boudjemaa A; Rogado J; Pasello G; Leighl NB; Arrieta O; Aujayeb A; Batra U; Azzam AY; Unk M; Azab MA; Zhumagaliyeva AN; Gomez-Martin C; Blaquier JB; Geraedts E; Mountzios G; Serrano-Montero G; Reinmuth N; et alii...

Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis. in JTO clinical and research reports / JTO Clin Res Rep. 2022 Aug;3(8):100335. doi: 10.1016/j.jtocrr.2022.100335. Epub 2022 May 20.

2022
AOU Alessandria

Bestvina CM; Whisenant JG; Torri V; Cortellini A; Wakelee H; Peters S; Roca E; De Toma A; Hirsch FR; Mamdani H; Halmos B; Arrieta O; Metivier AC; Fidler MJ; Rogado J; Presley CJ; Mascaux C; Genova C; Blaquier JB; Addeo A; Finocchiaro G; Khan H; Mazieres J; Morgillo F; Bar J; Aujayeb A; Mountzios G; Scotti V; Grosso F; et alii...

Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS Study. in Clinical lung cancer / Clin Lung Cancer. 2021 Jul;22(4):361-370.e3. doi: 10.1016/j.cllc.2020.06.028. Epub 2020 Jul 3.

2021
AOU Alessandria

Maconi A; Canova S; Rulli E; Torri V; Galli F; Hollander L; Sperandi F; Tiseo M; Pasello G; Zucali PA; Carlucci L; Grosso F; Cortinovis D; Bidoli P; Ceresoli GL; D'Incalci M;

Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088). in Trials / Trials. 2020 Jul 25;21(1):678. doi: 10.1186/s13063-020-04568-9.

2020
AOU Alessandria

Monsellato I; Garibaldi E; Cassinotti E; Baldari L; Boni L; Elmore U; Delpini R; Rosati R; Perinotti R; Alongi F; Bertocchi E; Gori S; Ruffo G; Pernazza G; Pulighe F; De Nisco C; Morpurgo E; Contardo T; Mammano E; Perna F; Menegatti B; Coratti A; Buccianti P; Balestri R; Ceccarelli C; Cavaliere D; Solaini L; Ercolani G; Traverso E; et alii...

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. in The Lancet. Oncology / Lancet Oncol. 2020 Jul;21(7):914-922. doi: 10.1016/S1470-2045(20)30314-4. Epub 2020 Jun 12.

2020
AOU Alessandria

Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; et alii...

Correction to: Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2020 Feb 17;20(1):128. doi: 10.1186/s12885-020-6632-y.

2020
AOU Alessandria
AOU Novara

Numico G; Franzone P; Priora F; Fusco V; Rossi M; Traverso E; Ercolani G; Cavaliere D; Solaini L; Torri V; Ceccarelli C; Balestri R; Buccianti P; Baroffio P; Gentilli S; Coratti A; Menegatti B; Perna F; Rosati R; Delpini R; Mammano E; Elmore U; Contardo T; Perinotti R; Morpurgo E; De Nisco C; Pulighe F; Pernazza G; Boni L; et alii...

Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2019 Dec 16;19(1):1215. doi: 10.1186/s12885-019-6271-3.

2019
AOU Alessandria
AOU Novara

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma. in British journal of cancer / Br J Cancer. 2018 Aug;119(5):565-571. doi: 10.1038/s41416-018-0190-y. Epub 2018 Jul 30.

2018
AOU Alessandria

Gadducci A; Grosso F; Scambia G; Raspagliesi F; Colombo N; Grignani G; Casali P; Sanfilippo R; Buonadonna A; Santoro A; Bruzzone M; Artioli G; Lorusso D; Biagioli E; Fossati R; Galli F; Negri E; Rulli E; Torri V; D'Incalci M;